Phase I study of docetaxel and temsirolimus in refractory solid tumors.

e13149 Background: Temsirolimus (CCI-779) is an ester analog of rapamycin and a selective inhibitor of the mammalian target of rapamycin (mTOR). Temsirolimus blocks the signals of at least two sepa...